NewsRadio WFLA (WFLA-AM)
NewsRadio WFLA (WFLA-AM)
DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23
DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23
DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23
Saturday 19th August 2023
Learn about Leqembi, the new Alzheimer's drug, and its potential impact in this insightful episode of American Medicine Today with Dr. Nikhil Palekar.
Explicit
10 minutes
Informative
Hopeful
Empowering
Thought-provoking
Supportive
About this podcast
Author:
NewsRadio WFLA (WFLA-AM)
Overview:
Categories:
Innovative Treatments & Recovery Paths
Holistic Health Innovations
Innovative Healing Arts
Sexual Stigmas & Myths
Mindful Recovery
Links:
Visit site
Episodes:
1002 (View all)
Do you want to link to this podcast?
Get the buttons here!Leqembi: A New Hope in Alzheimer's Treatment
Episode Overview
- Leqembi: A groundbreaking drug slowing cognitive decline by 30%
- Dr. Alfred Benatti shares intriguing experiences with cervical spine decompression and its effects on cognitive abilities
- Dr. Palakar emphasizes the importance of early detection and treatment for Alzheimer's
- Discussion on the potential vascular component of Alzheimer's
- Valuable resources shared for those seeking further information and assistance
This medication and a group of these medications called monoclonal antibodies, they actually go and bind to these amyloid plaques and clear them out of the brain. So obviously this isn't a cure per se, but it's definitely groundbreaking.
Ever wondered if there's a breakthrough on the horizon for Alzheimer's treatment? In this episode of 'American Medicine Today', hosts Kimberly Benatti and Ethan Uecker sit down with Dr. Nikhil Palekar, Director of the Stony Brook Center of Excellence for Alzheimer's Disease, to discuss the FDA-approved drug Leqembi. This new medication is being celebrated as a significant advancement in the fight against Alzheimer's. Dr.
Palekar explains how Leqembi works by targeting and removing amyloid plaques from the brain, potentially slowing cognitive decline by up to 30%. While it's not a cure, it offers hope for those with mild symptoms. Adding another layer to the conversation, Dr. Alfred Benatti shares intriguing cases where cervical spine decompression has positively affected cognitive abilities in patients showing early signs of Alzheimer's.
This opens up a fascinating discussion about the possible vascular aspects of the disease and underscores the importance of early detection and intervention. Dr. Palekar wraps up the episode by providing valuable resources for those seeking more information and support, leaving listeners with a renewed sense of hope and encouragement. If you're looking to stay informed about cutting-edge treatments and innovative approaches to Alzheimer's, this episode is a must-listen.